TREM2 receptor protects against complement-mediated synaptic loss by binding to complement C1q during neurodegeneration-Reference-Cited by-同舟云学术

TREM2 receptor protects against complement-mediated synaptic loss by binding to complement C1q during neurodegeneration

Published:2023-08 Issue:8 Volume:56 Page:1794-1808.e8
ISSN:1074-7613
Container-title:Immunity
language:en
Short-container-title:Immunity

Author:

Zhong Li,Sheng Xuan,Wang Wanbing,Li Yanzhong,Zhuo Rengong,Wang Kai,Zhang Lianshuai,Hu Dan-Dan,Hong Yujuan,Chen Linting,Rao Hengjun,Li Tingting,Chen Muyang,Lin Zhihao,Zhang Yun-wu,Wang Xin,Yan Xiao-Xin,Chen Xiaochun,Bu Guojun,Chen Xiao-Fen

Publisher

Elsevier BV

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference56 articles.

1. Complement in neurological disorders and emerging complement-targeted therapeutics;Dalakas;Nat. Rev. Neurol.,2020

2. Complement activation by neurofibrillary tangles in Alzheimer's disease;Shen;Neurosci. Lett.,2001

3. Beta-amyloid activates complement by binding to a specific region of the collagen-like domain of the C1q A chain;Jiang;J. Immunol.,1994

4. Complement activation by beta-amyloid in Alzheimer disease;Rogers;Proc. Natl. Acad. Sci. USA,1992

5. Changes in the synaptic proteome in tauopathy and rescue of tau-induced synapse loss by C1q antibodies;Dejanovic;Neuron,2018

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging microglial biology highlights potential therapeutic targets for Alzheimer's disease;Ageing Research Reviews;2024-11

2. Microglial activation and polarization in type 2 diabetes-related cognitive impairment: A focused review of pathogenesis;Neuroscience & Biobehavioral Reviews;2024-10

3. Edaravone Dexborneol ameliorates the cognitive deficits of APP/PS1 mice by inhibiting TLR4/MAPK signaling pathway via upregulating TREM2;Neuropharmacology;2024-09

4. Recent advances in Alzheimer’s disease: mechanisms, clinical trials and new drug development strategies;Signal Transduction and Targeted Therapy;2024-08-23

5. Neurotropic murine coronavirus mediated demyelination: Factors dampening pathogenesis;Journal of Neuroimmunology;2024-08